What Is Thymosin Alpha-1?
Thymosin Alpha-1 is a 28-amino-acid acetylated peptide. It was originally isolated from calf thymus and is classified as a thymic peptide. Its amino-terminal sequence corresponds to the first 28 residues of prothymosin alpha.
Chemically, Thymosin Alpha-1 is a highly acidic polypeptide with an acetylated N-terminus. Its established sequence is SDAAVDTSSEITTKDLKEKKEVVEEAEN.
Research Overview Table
Chemical and Molecular Characteristics
Certificates:
Mechanism of Action Under Investigation
Published experimental studies have linked Thymosin Alpha-1 to TLR9/MyD88-dependent signaling, particularly in dendritic cells and plasmacytoid dendritic cells. In a murine cytomegalovirus model, TLR9 and MyD88 were required for signaling associated with IRF7 activation. However, a direct physical interaction between Thymosin Alpha-1 and TLR9 has not been established.
Other experimental studies identified TRAF6, IKK, NF-κB, p38, and JNK within Thymosin Alpha-1-associated signaling. In cultured macrophages and fibroblasts, TRAF6 was required for IKK and NF-κB activation, while IRAK4 contributed to IKK and PKCζ activation. Separate membrane studies found that Thymosin Alpha-1 interacts with negatively charged phosphatidylserine-containing membranes. The precise initiating molecular interaction remains unresolved.
Scientific Research Context
Researchers have investigated thymosin alpha-1 in experimental immunology, with published studies examining immune-cell biology. Laboratory research includes in vitro studies using human and murine dendritic cells and lymphocytes, as well as preclinical animal studies. Researchers have examined cellular differentiation, maturation, cytokine responses and other immune-cell changes in these experimental systems. The evidence for these biological investigations is derived primarily from in vitro experiments and preclinical animal models, although human clinical studies have also been reported.
Thymosin Alpha-1 Biology and Biological Pathways
Primary Biological Function
Thymosin Alpha-1 has been investigated in relation to dendritic-cell differentiation and maturation and lymphocyte function. Published studies have examined dendritic-cell surface markers, antigen uptake, T-cell stimulation, lymphocyte differentiation, and cytokine production. These findings place dendritic cells and lymphocytes among the main biological systems studied in relation to Thymosin Alpha-1.
Relevant Metabolic or Signaling Pathways
Published research has examined Thymosin Alpha-1 in relation to TLR9/MyD88 signaling, type I interferon signaling, NF-κB and MAPK pathways and the IDO-mediated tryptophan catabolism pathway. These pathways are relevant to research on dendritic-cell function, cytokine signaling, and immune regulation. Studies have also examined IRF7 within TLR9-dependent signaling and IDO activity following Thymosin Alpha-1 exposure.
Tissue-Specific Biology
Published studies have localized Thymosin Alpha-1 to thymic epithelial cells, including epithelial cells in the medulla and cortical surface of the human thymus. Researchers have also identified native Thymosin Alpha-1 in calf thymus and several lymphoid and non lymphoid tissues. Studies of its precursor, prothymosin alpha, show a broader tissue distribution, including lymphoid tissues such as the thymus, spleen, lymph nodes, and tonsils.
Experimental Biomarkers
Published studies have measured CD40, CD80 and MHC class I and II surface expression when examining dendritic-cell differentiation and maturation. Other reported measurements include antigen uptake, CD4 expression, T-cell proliferation, IL-6, TNF-α, IL-8, type I interferons, and IDO activity. These markers and measurements provide experimental readouts of changes in dendritic-cell phenotype, lymphocyte responses, and cytokine production.
Laboratory Investigation Methods
Published studies have used flow cytometry to assess dendritic-cell surface markers and lymphocyte populations, while ELISA and multiplex cytokine assays have measured cytokine concentrations. Mixed-lymphocyte reaction assays have been used to assess T-cell proliferation following dendritic-cell exposure. Other studies have used immunohistochemistry and immunofluorescence to examine cellular or tissue localization.
Experimental Models Used in Published Research
Thymosin Alpha-1 has been examined in human and animal cell systems, as well as whole-animal models. The published literature includes cultured human dendritic cells and lymphocytes, murine immune-cell systems and mouse and rat models. Each model has limitations related to cellular isolation, species-specific biology, or differences between experimental systems and human physiology.
Human Cell-Based Models
Human peripheral-blood-derived dendritic cells and lymphocytes have been used as experimental models. Their main limitation is that isolated or cultured cells do not reproduce the full tissue environment, interactions among multiple cell types, or systemic physiology.
Murine Cell-Based Models
Mouse dendritic cells and lymphocytes have been used in cell-based experiments. The main limitation is species-specific variation in immune-cell biology, which can make findings from murine cells difficult to apply directly to human cells.
Mouse Models
Whole-mouse models have been used in several areas of Thymosin Alpha-1 research, including infectious, inflammatory, and tumor-related studies. Their main limitation is the biological difference between murine and human immune systems, which restricts direct translation of findings to humans.
Rat Models
Researchers have used rat models in Thymosin Alpha-1 research, including cancer, inflammatory, neurological, and immune-related models. Their main limitation is that species-specific differences in physiology and immune function can limit direct translation of findings to human biology.
Published Scientific Research
Dendritic-Cell Biology
Researchers have investigated Thymosin Alpha-1 in relation to dendritic-cell differentiation, maturation, antigen uptake, antigen presentation, and T-cell stimulation. Further research has examined dendritic-cell responses during HCMV infection, including changes in dendritic-cell phenotype and their interaction with CD4+ and CD8+ T cells. These investigations have been reported in several independent studies rather than a single experimental system.
T-Cell and Lymphocyte Biology
Thymosin Alpha-1 has been investigated in relation to lymphocyte proliferation, T-cell responses, CD4+ and CD8+ T-cell populations, and lymphocyte gene expression. Research has also examined changes in T-cell responses following exposure to Thymosin Alpha-1-treated dendritic cells. Separate studies have investigated lymphocyte responses in peripheral blood and intestinal lymphocyte populations.
Infectious Disease Research
Infectious-disease research has examined Thymosin Alpha-1 in hepatitis B and C, sepsis, influenza, HCMV infection and COVID-19. Investigations have focused on immune responses during infection, including T-cell populations, natural killer cells, monocyte HLA-DR expression, and inflammatory responses. Sepsis and viral infections account for much of the published clinical research.
Cancer Research
Cancer research has examined Thymosin Alpha-1 in relation to tumor-associated immune responses, dendritic-cell function, T-cell activity and interactions with cancer treatments. More recent research has investigated CD8+ T-cell responses in breast cancer and dendritic-cell responses following chemotherapy.
Transplantation and Immune Reconstitution
Research in this area has examined immune-cell recovery after hematopoietic stem-cell transplantation, including T-cell reconstitution, dendritic-cell function, and the development of pathogen-specific T-cell responses. Studies have also examined immune responses to infections occurring after transplantation.
Immune Tolerance and Inflammatory Regulation
Research has examined Thymosin Alpha-1 in relation to immune tolerance, dendritic-cell regulation, IDO activity, IL-10 production and regulatory T-cell generation. Studies have also investigated its role in the balance between inflammatory and regulatory immune responses.
Limitations of Current Research
Evidence Is Predominantly Preclinical
A substantial part of the biological literature comes from cell-based and animal research. These studies are useful for examining cellular and biological processes, but findings from isolated systems or animals cannot be assumed to predict human responses. Human clinical research is therefore important for assessing whether experimental observations translate to people.
Human Clinical Evidence
Human data are difficult to interpret because trials have differed in patient groups, treatment schedules, outcome measures and study quality. Earlier reviews also noted small sample sizes and weak study designs. More recent analyses continue to report uncertainty, with differences between individual trials and pooled results.
Species Differences
Species-specific differences in immune-cell composition, receptor expression, signaling, and immune responses can affect how closely experimental findings reflect human biology. These differences create uncertainty when biological observations from different species are compared with human findings.
Study Design Limitations
Clinical studies have differed in participant populations, sample sizes, treatment protocols, outcome measures and study quality. Systematic reviews of earlier sepsis trials specifically identified small samples and inadequate reporting as limitations. More recent analyses have also identified heterogeneity between trials and insufficient sample size for some analyses.
Independent Replication
Results have varied from one clinical trial to another. Findings reported in earlier studies were not consistently seen in later trials. As a result, there is still some uncertainty about whether the reported effects can be reproduced reliably in different patient groups and clinical settings.
Long-Term Evidence
Long-term data are available for some clinical research areas, including a chronic hepatitis B trial with follow-up extending to 12 months after treatment. However, long-term evidence is not equally available across the different biological and clinical settings studied. The duration and completeness of follow-up therefore vary between research areas.
Analytical Documentation
HPLC separates chemical components and can be used to assess chromatographic purity and identify related impurities.
LC-MS combines chromatographic separation with mass measurement. It can support identity testing and help detect related chemical components.
NMR provides structural information and can be used when additional chemical characterization is appropriate. It can also provide information about molecular structure and chemical environment.
A Certificate of Analysis (CoA) records analytical results for a specific batch or lot, including reported identity and purity measurements. Analytical documentation provides measurable information about the chemical characteristics of research material and supports quality assessment. It verifies product identity and quality, not biological performance.
Storage and Laboratory Handling
Store the material at 2–8 °C. Follow the temperature range stated in the product documentation and avoid conditions that could affect material stability.
Use clean handling practices and limit unnecessary exposure during laboratory work. Qualified personnel should manage storage and handling and take appropriate steps to prevent contamination. Keep the material contained when not in use.
Why Researchers Choose Direct SARMs?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.
Frequently asked questions
Why choose us?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.